Found: 25
Select item for more details and to access through your institution.
Mortality in COVID‐19 hospitalizations with underlying hematologic malignancies in the United States.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 781, doi. 10.1002/hon.3173
- By:
- Publication type:
- Article
[<sup>18</sup>F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 674, doi. 10.1002/hon.3171
- By:
- Publication type:
- Article
Report of PRPF19 as a novel partner of RARG and the recurrence of interposition‐type fusion in variant acute promyelocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 784, doi. 10.1002/hon.3170
- By:
- Publication type:
- Article
Reducing the risks of nuclear war—The role of health professionals.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 605, doi. 10.1002/hon.3218
- By:
- Publication type:
- Article
Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 762, doi. 10.1002/hon.3189
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article
The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next‐generation sequencing in adult acute myeloid leukemia patients with the FLT3‐ITD mutation.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 733, doi. 10.1002/hon.3186
- By:
- Publication type:
- Article
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection‐related hospitalizations in multiple myeloma patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 718, doi. 10.1002/hon.3185
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 663, doi. 10.1002/hon.3174
- By:
- Publication type:
- Article
Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 753, doi. 10.1002/hon.3160
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 603, doi. 10.1002/hon.3021
- Publication type:
- Article
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 743, doi. 10.1002/hon.3159
- By:
- Publication type:
- Article
Revisiting the predictive role of 18F‐fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early‐stage favorable Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 608, doi. 10.1002/hon.3158
- By:
- Publication type:
- Article
LncRNA FEZF1‐AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 694, doi. 10.1002/hon.3157
- By:
- Publication type:
- Article
Significant reduction in the incidence of non‐coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID‐19 pandemic: An additional benefit of lockdown.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 683, doi. 10.1002/hon.3156
- By:
- Publication type:
- Article
A comprehensive analysis of coagulopathy during anti‐B cell maturation antigen chimeric antigen receptor‐T therapy in multiple myeloma, a retrospective study based on LEGEND‐2.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 704, doi. 10.1002/hon.3155
- By:
- Publication type:
- Article
A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 789, doi. 10.1002/hon.3136
- By:
- Publication type:
- Article
Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 725, doi. 10.1002/hon.3135
- By:
- Publication type:
- Article
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 771, doi. 10.1002/hon.3134
- By:
- Publication type:
- Article
Whole exome sequencing of primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorders.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 768, doi. 10.1002/hon.3133
- By:
- Publication type:
- Article
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 631, doi. 10.1002/hon.3132
- By:
- Publication type:
- Article
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 776, doi. 10.1002/hon.3130
- By:
- Publication type:
- Article
Myelodysplastic syndromes with ring sideroblasts.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 612, doi. 10.1002/hon.3125
- By:
- Publication type:
- Article
Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 621, doi. 10.1002/hon.3122
- By:
- Publication type:
- Article